MetLife Stock Price, News & Analysis

MetLife (NYSE: MET) will hold its third quarter 2025 earnings conference call and audio webcast on Thursday, November 6, 2025, from 9:00–10:00 a.m. ET.

The call follows MetLife's issuance of its Q3 2025 earnings news release and Third Quarter 2025 Financial Supplement on Wednesday, November 5, 2025 after market close. Materials and the live webcast will be available on the MetLife Investor Relations webpage.

A live registration link is provided for listeners, and replays will be available by telephone and online beginning 11:00 a.m. ET on November 6, 2025 through 11:59 p.m. ET on November 13, 2025.

MetLife (NYSE: MET) announced a fourth quarter 2025 common stock dividend of $0.5675 per share. The dividend is payable on Dec. 9, 2025 to shareholders of record as of Nov. 4, 2025. The release restates MetLife's business focus on insurance, annuities, employee benefits and asset management and notes forward-looking statement cautions tied to SEC filings.

MetLife (NYSE:MET) reports from its 2025 Pension Risk Transfer Poll show U.S. plan sponsors accelerating de‑risking: 94% of defined benefit plans with de‑risking goals intend to fully divest liabilities and 80% plan to do so within five years. The poll cites market volatility (45%) and interest rate changes (41%) as top catalysts, and finds 62% prioritizing participant data cleansing. Market scale has grown from under $14B in 2015 to nearly $52B in 2024, with PRT volumes projected to reach $100B by 2030. The average planned transfer size reported is $608 million, and the market now lists over 20 active insurers, enabling split deals and reinsurance strategies.

MetLife (NYSE: MET) has released concerning new workforce data showing significant declines in employee sentiment. The study reveals that only 53% of employees feel valued (down 10% from last year) and employee engagement has dropped to 66% (down 6% from 2024).

Despite 75% of employees planning to stay with their current employers, the research identified troubling trends: 39% report burnout (up 3%) and 56% feel less connected to work. The study also exposed significant gaps in benefits coverage, with 90% of employees interested in Accident and Critical Illness insurance, but only 32% and 26% enrolled, respectively.

MetLife's research demonstrates that employees who understand and are satisfied with their benefits are 1.4 times more likely to feel engaged and 1.2 times more likely to be productive at work.

MetLife (NYSE:MET) has announced a significant three-year partnership with Global Citizen, the world's largest anti-poverty movement. The partnership includes a $9 million commitment from MetLife Foundation to the FIFA Global Citizen Education Fund, which aims to raise $100 million to provide quality education and sport access for children globally.

The collaboration leverages MetLife's expertise in financial services and community support, building on MetLife Foundation's legacy of over $1 billion in giving since 1976. The partnership will focus on financial health, educational opportunities, and community resilience, including support for Global Citizen campaigns and the Global Citizen Festival in New York's Central Park.

MetLife (NYSE: MET) has issued a warning to shareholders regarding an unsolicited mini-tender offer from Potemkin Limited. The offer seeks to purchase up to 10,000 shares (approximately 0.00002%) of MetLife's common stock at $53.00 per share, which is 34.42% below the current market price of $80.82 as of September 12, 2025.

MetLife strongly recommends shareholders reject this offer and exercise caution, highlighting that mini-tender offers avoid many SEC disclosure requirements by targeting less than 5% of shares outstanding. The offer is set to expire on October 7, 2025, and shareholders who have already tendered their shares can withdraw them before the deadline.

MetLife (NYSE:MET) has announced the launch of a new Cancer Support benefit through a strategic partnership with Private Health Management. The benefit, available from January 1, 2026, will enhance MetLife's Critical Illness Insurance offering by providing personalized cancer care navigation and financial support.

The service comes as cancer diagnoses are expected to exceed 2 million cases in 2025. Through Private Health Management's expertise, the program has demonstrated significant outcomes, including a 20% reduction in average cost per case, 15% reduction in unnecessary treatments, and 70% modification of treatment plans for optimal care.

MetLife (NYSE: MET) has announced the complete redemption of its Series G Preferred Stock, scheduled for September 15, 2025. The redemption will be executed at $1,000 per share, which represents the liquidation preference value. Shareholders will receive a final regular dividend of $19.250 per share, paid separately to holders of record as of August 29, 2025.

The redemption will be processed through The Depository Trust Company (DTC), with Computershare Trust Company, N.A. serving as the redemption agent. After the redemption date, all dividends on the Series G Preferred Stock will cease to accrue.

MetLife Investment Management (MIM), the institutional asset management arm of MetLife Inc. (NYSE: MET), has appointed Geert Henckens as global head of Private Fixed Income. Henckens, who previously served as global head of Investment Grade Private Credit since 2023, succeeds Brian Funk, who became MIM's president in June 2025.

The appointment comes as MIM continues to strengthen its private fixed income platform, which originated $21.6 billion in private fixed income transactions in 2024. As of June 30, 2025, MIM manages $154.8 billion in private fixed income assets and has total assets under management of $624.3 billion. Henckens will lead teams focused on originating and managing private asset investments, including corporate and infrastructure debt, private asset-based finance, and middle market direct lending.